The longest stock rally in 30 years finally hits a wall

For weeks, Wall Street treated the war in the Gulf as someone else’s problem. Strong company earnings carried stocks to record after record, and investors looked past the fighting. On Wednesday, they stopped looking past it.

The streak breaks

The S&P 500 — the main index of big US companies — snapped a nine-day winning streak, its longest run since 1995 [9][19]. Stocks fell and government bond yields rose as renewed US–Iran fighting pulled investors’ attention back to what the war does to prices [2]. The trigger was a fresh flare-up: an Iranian attack on Kuwait and US strikes near the Strait of Hormuz, the shipping lane that carries much of the world’s oil [2].

The mechanism matters more than the one-day drop. Higher oil feeds inflation, and inflation pushes up the interest rates that lenders demand. The yield on the 30-year US Treasury — the interest the government pays to borrow for 30 years — hit 4.98%, a 20-year high, the most since June 2007 [3]. A bond yield is just the return a lender earns; when it climbs, two things happen. Borrowing gets dearer for everyone, from governments to homebuyers. And safe bonds start to compete with risky stocks for investors’ money. After a record-setting run, that competition is the rally’s real test.

Boring bonds are interesting again

Here’s the quieter story underneath. For most of the last decade, government bonds paid almost nothing, so savers had little reason to hold them. At nearly 5%, that’s changed.

“This is one of those moments where bonds are finally doing what investors have wanted them to do for years, which is pay you a real yield again,” said Britton Williams, a financial planner at Calamita Wealth Management [3]. A “real yield” means a return that beats inflation — actual purchasing power, not just a bigger number. The advisers quoted urged caution rather than excitement: locking your money into a 30-year bond at a multi-year-high rate sounds clever, but it ties that money up for decades, and what suits a 70-year-old who needs steady income doesn’t suit a 30-year-old [3]. The point for an ordinary saver isn’t to rush — it’s that the risk-free option is finally worth comparing against everything else.

The split inside the market

Look under the index and the move wasn’t uniform. Chipmakers — Broadcom, Marvell, Nvidia — kept climbing on the AI building-out boom, while software stocks faded; money rotated from one tech corner to another rather than leaving altogether [19].

A separate worry hit the firms that run private credit — lending done outside banks, by investment houses straight to companies. Shares of KKR, Blackstone, and Blue Owl tumbled as “private-market jitters” returned [19]. Private credit has ballooned in recent years precisely because rates were low and investors chased higher returns; now that rates are high and the economy looks wobblier, investors are asking who’s holding loans that might not be repaid. When the cost of money turns, the businesses built on cheap money feel it first.

Money leaves the casino

Risk-taking cooled at the edges, too. Bitcoin fell 4% to a more-than-three-month low, and — more tellingly — CNBC reported that long-term “high-conviction” holders, the ones who usually sit tight, have turned into sellers [7][8]. When the steadiest hands start selling, it says something about the mood that a single price drop doesn’t.

Gold tells the opposite half of the same story. After its strongest year in over four decades, bullion hit an all-time high of $5,595 a troy ounce in January, then fell about 20% as high oil prices ate into the disposable income of the retail buyers who pile in [4]. But the consultancy Metals Focus says physical investment — people buying actual bars and coins — is set to overtake jewellery as the single biggest source of gold demand [4]. Stripped of the jargon: when people are nervous, they stop buying gold to wear and start buying it to keep.

Around the currency markets

The dollar clung to a two-month high as Gulf hostilities flared — in scary moments, global money still runs to the US currency for safety [16]. The flip side is Japan: the yen wobbled near the level where the government has previously stepped in to prop it up, and the prospect of the Bank of Japan finally raising its own rock-bottom interest rates weighed on Japanese government bonds [5][16]. A strong dollar and a weak yen are two ends of the same seesaw, and both are being tipped by where interest rates are heading.

The deal boom nobody’s talking about

Away from the day’s red screens, one corner of finance is having its best year in ages: drug companies are buying each other at a furious pace. Biotech mergers and acquisitions have hit $106 billion across more than 200 deals so far in 2026, on track for the strongest year since before Covid [10]. One banker described big pharma as “buying stuff like it’s going out of fashion” [10].

The reason is unglamorous but real: large drugmakers face a wave of their best-selling medicines losing patent protection in the coming years, which lets cheaper copies flood in and craters revenue. Buying a smaller company with promising new drugs is how they fill the hole. It’s a useful reminder that beneath the war headlines and the rate-hike drama, a lot of finance is just companies doing arithmetic about their own survival — and that the deal market can run hot even on a day the stock market runs scared.